Analyst consensus rating

Neurogene Analyst Rating: Strong Buy

Direct answer

Neurogene's consensus rating is Strong Buy.

8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $77.63.
Forecast evidence checked November 21, 2026.

Get free Neurogene email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$22.15
Average price target
$77.63
High price target
$166.00
Low price target
$46.00
Low target gap
+107.7%
Target upside
+250.5%
High target gap
+649.4%
Target range width
541.8%
Consensus rating
Strong Buy
Analysts
8
Evidence date
November 21, 2026
Valid through
November 28, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Neurogene?

Neurogene has a verified Strong Buy consensus. The same dataset has an average price target of $77.63.

How far are Neurogene's low and high targets from the recorded price?

The low target implies +107.7%, while the high target implies +649.4%.

How many analysts are included in Neurogene's consensus?

The verified consensus includes 8 analysts.

How is Neurogene's target upside or downside calculated?

The average target of $77.63 is divided by the recorded price of $22.15, then one is subtracted to produce +250.5%. This does not guarantee a future return.

When was Neurogene's analyst forecast verified?

The data was verified on 2026-11-21. The dataset is valid through 2026-11-28.